The prevalence of inherited thrombophilias in a Caucasian Australian population

Pathology

Volumn 37, Issue 2, 2005, Pages 160-163

  Gibson, Catherine S ^a,b   MacLennan, Alastair H ^a   Rudzki, Zbigniew ^c   Hague, William M ^a   Haan, Eric A ^a,b   Sharpe, Phillipa ^b   Priest, Kevin ^d   Chan, Annabelle ^d   Dekker, Gustaaf A ^a   Goldwater, Paul N ^b   Khong, T Yee ^b   Morton, Mark R ^a   Ranieri, Enzo ^b   Scott, Heather ^b   Tapp, Heather ^b   Casey, Graeme ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^d DEPARTMENT OF HUMAN SERVICES   (Australia)

Author keywords

Australian; Caucasian; Factor V Leiden; Inherited thrombophilias; MTHFR; Prevalence; Prothrombin

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ARTICLE; AUSTRALIA; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INHERITANCE; NEWBORN; NEWBORN SCREENING; PREVALENCE; THROMBOPHILIA;

EID: 17844409607     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020500058250     Document Type: Article

References (17)

1. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-31.
2. Computer Programs for Epidemiologists: PEPI. v 4.0. Salt Lake City: Sagebrush Press, 2001.
3. Pecheniuk N, Marsh S, Walsh T. Multiple analysis of three common genetic alterations associated with thrombophilia. Blood Coag Fibrinolysis 2000; 11: 183-9.
4. Rees D. The population genetics of factor V Leiden (Arg506Gln). Br J Haematol 1996; 95: 579-86.
5. Wang XL, Wang J, McCredie RM, et al. Polymorphisms of factor V, factor VII, and fibrinogen genes. Relevance to severity of coronary artery disease. Arterioscler Thromb Vasc Biol 1997; 17: 246-51.
6. Wilcken B, Bamforth F, Li Z, et al. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 2003; 40: 619-25.
7. Rosendaal F, Koster T, Vandenbrouke J, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein resistance). Blood 1995; 85: 1504-8.
8. Lindmarker P, Schulman S, Sten-Linder M, et al. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation. Thromb Haemostat 1999; 81: 684-9.
9. Reitsma PH. Genetic heterogeneity in hereditary thrombophilia. Haemostasis 2000; 30: 1-10.
10. Walker I. Thrombophilia in pregnancy. J Clin Pathol 2000; 53: 573-80.
11. Higgins J. Pregnancy and the impact of inherited thrombophilias. Aust N Z J Obstet Gynaecol 2000; 40: 118-21.
12. Souto JC, Coll I, Llobet D, et al. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost 1998; 80: 366-9.
13. Jacques P, Bostom A, Williams R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93: 7-9.
14. D'Angelo A, Beltrametti C. Homocysteine in Health and Disease. Cambridge: Cambridge University Press, Venous disease.
15. Van der Put N, Gabreels E, Smeitink J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-51.
16. Weisberg IS, Jacques PF, Selhub J, et al. The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001; 156: 409-15.
17. Esfahani ST, Cogger EA, Caudill MA. Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J Am Diet Assoc 2003; 103: 200-7.